Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Tanabe Pharma America, Inc.
Terminated
Futility was met.
Other terminated trials from Tanabe Pharma America, Inc.
More terminations from Tanabe Pharma America, Inc.
This PHASE3 trial investigates ALS and is currently terminated or withdrawn. Tanabe Pharma America, Inc. leads this study, which shows 30 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
30 versions recorded-
Jan 2026 — Present [monthly]
Terminated PHASE3
-
Oct 2025 — Jan 2026 [monthly]
Terminated PHASE3
-
Sep 2025 — Oct 2025 [monthly]
Terminated PHASE3
-
Apr 2025 — Sep 2025 [monthly]
Terminated PHASE3
-
Sep 2024 — Apr 2025 [monthly]
Terminated PHASE3
▶ Show 25 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Nov 2023 — Jul 2024 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Oct 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE3
-
Jun 2023 — Oct 2023 [monthly]
Active Not Recruiting PHASE3
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE3
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting PHASE3
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2023 — Mar 2023 [monthly]
Recruiting PHASE3
-
Jun 2022 — Jan 2023 [monthly]
Recruiting PHASE3
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE3
-
Apr 2022 — May 2022 [monthly]
Recruiting PHASE3
-
Mar 2022 — Apr 2022 [monthly]
Recruiting PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE3
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE3
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE3
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE3
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE3
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Tanabe Pharma America, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .